Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ardent Health (ARDT) Gains from Investment Securities (2023 - 2025)

Historic Gains from Investment Securities for Ardent Health (ARDT) over the last 3 years, with Q3 2025 value amounting to -$172000.0.

  • Ardent Health's Gains from Investment Securities fell 12160.8% to -$172000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $41.0 million, marking a year-over-year increase of 11724.39%. This contributed to the annual value of $41.6 million for FY2024, which is 11408.43% up from last year.
  • According to the latest figures from Q3 2025, Ardent Health's Gains from Investment Securities is -$172000.0, which was down 12160.8% from $50000.0 recorded in Q2 2025.
  • Ardent Health's 5-year Gains from Investment Securities high stood at $40.9 million for Q4 2024, and its period low was -$236000.0 during Q3 2023.
  • Over the past 3 years, Ardent Health's median Gains from Investment Securities value was $132000.0 (recorded in 2025), while the average stood at $7.4 million.
  • Per our database at Business Quant, Ardent Health's Gains from Investment Securities skyrocketed by 43728.81% in 2024 and then crashed by 12160.8% in 2025.
  • Quarter analysis of 3 years shows Ardent Health's Gains from Investment Securities stood at $18.1 million in 2023, then surged by 125.59% to $40.9 million in 2024, then tumbled by 100.42% to -$172000.0 in 2025.
  • Its last three reported values are -$172000.0 in Q3 2025, $50000.0 for Q2 2025, and $214000.0 during Q1 2025.